Abstract
Three-component condensation of ethyl 1-R-2-phenyl-4,5-dihydro-4,5-dioxo-1H-pyrrole-3-carboxylates, malononitrile, and acyclic enols (acetylacetone, alkyl acetoacetates, and ethyl benzoylacetate) afforded substituted ethyl 9-amino-10-cyano-1-oxo-3-phenyl-8-oxa-2-azaspiro[4.5]deca-3,6,9-triene-4-carboxylates. The products are interesting from the viewpoint of medicinal chemistry.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
We previously studied three-component reactions of 1H-pyrrole-2,3-diones with malononitrile and six-membered carbo- and heterocyclic enols (5,5-dimethylcyclohexane-1,3-dione and 4-hydroxycoumarin), which led to the formation of spiro[chromene-4,3′-pyrroles] and spiro[pyrano[3,2-c]chromene-4,3′-pyrroles], respectively [1, 2]. Analogous reactions of 1H-pyrrole-2,3-diones with malononitrile and five-membered carbo- and heterocyclic enols [indan-1,3-dione, cyclopentane-1,3-dione, and furan-2,4(3H,5H)-dione] afforded spiro[indeno[1,2-b]pyran-4,3′-pyrroles], spiro[cyclopenta[b]pyran-4,3′-pyrroles], and spiro[furo[3,4-b]pyran-4,3′-pyrroles], respectively [3, 4]. Three-component reactions of 1H-pyrrole-2,3-diones with malononitrile and acyclic enols have not been reported so far.
By heating ethyl 1-R-2-phenyl-4,5-dihydro-4,5-dioxo-1H-pyrrole-3-carboxylates 1a–1d, malononitrile, and acyclic enols 2a–2d at a ratio of 1:1:4 in boiling anhydrous acetonitrile in the presence of triethylamine (20 mol %) for 19– 20 h (HPLC/MS monitoring) we obtained substituted 9-amino-10-cyano-1-oxo-3-phenyl-8-oxa-2-azaspiro[4.5]deca-3,6,9-triene-4-carboxylates 3a–3g (Scheme 1). Unlike similar reactions with cyclic enols [1–4], the reaction with enols 2a–2d required more severe conditions, i.e., prolonged heating and the use of excess enol (4 equiv).
Compounds 3a–3g are high-melting colorless crystalline solids readily soluble in DMSO and acetone, poorly soluble in ethanol and toluene, and insoluble in alkanes and water. Their IR spectra showed N–H stretching band at 3175–3502 cm–1), C≡N stretching band at 2185–2198 cm–1, and carbonyl stretching bands in the region 1626–1758 cm–1. The 1H NMR spectra of 3a–3g contained signals for aromatic protons, protons in the substituents R1, R2, R3, ester ethoxy group (δ 0.78–0.90 t and 3.73–3.96 ppm, m) and amino group (δ 7.11–7.28 ppm, br.s). In the 13C NMR spectra of 3a–3g we observed signals of lactam (δC 178.1–179.0 ppm), ester (δC 161.3– 165.0 ppm), and ketone (δC 197.1 ppm, 3b) carbonyl carbon atoms, as well as a signal of the spiro carbon atom at δC 49.8– 50.7 ppm.
The structure of compound 3a was confirmed by X-ray analysis. According to the X-ray diffraction data (Fig. 1), compound 3a crystallized in the centrosymmetric space group belonging to the monoclinic crystal system. The pyran ring adopts a distorted boat conformation with the C2 and O4 atoms deviating from the C5C6C7C8 plane by 0.17 and 0.08 Å, respectively. The pyrrole ring is planar within 0.04 Å. The ethoxycarbonyl and methoxycarbonyl groups are turned through small angles relative to the pyrrole and pyran rings, respectively; the dihedral angles are C7C8C9O5 7.5(4)° and C2C8C9O6 3.5(3)°. Molecules 3a in crystal are linked to form infinite two-dimensional networks through intermolecular hydrogen bonds N3–H3A···O1 [–x, –0.5 + y, 0.5 – z] and N3–H3B···O1 [x, 0.5 – y, –0.5 + z].
Presumably, the formation of compounds 3a–3g involves initial condensation of pyrroledione 1 through the ketone carbonyl group with malononitrile and subsequent addition of the β-CH and OH groups of the enol tautomer of 2 to the C3 atom of the pyrrole ring in intermediate 4 and carbon atom of the cyano group, respectively. Analogous spiro heterocyclization was observed previously in the reaction of 2-(5-aryl-4-methyl-2-oxo-1,2-dihydro-3H-pyrrol-3-ylidene)malononitriles (analogs of 4) with ethyl acetoacetate [5].
The reaction described in this work is the first example of three-component spiro heterocyclization of substituted 1H-pyrrole-2,3-diones with malononitrile and acyclic enols with the formation of difficultly accessible 8-oxa-2-azaspiro[4.5]deca-3,6,9-triene system. Compounds containing a 2-amino-3-cyano-4H-pyran fragment are known to exhibit cytotoxicity [6] and antimicrobial activity [7–9].
EXPERIMENTAL
The IR spectra were recorded in mineral oil on a Perkin Elmer Spectrum Two spectrometer. The 1H and 13C NMR spectra were measured on a Bruker Avance III HD 400 spectrometer at 400 and 100 MHz, respectively, using DMSO-d6 as solvent and hexamethyldisiloxane as internal standard. Elemental analysis was performed with a Vario Micro cube analyzer. The purity of the isolated compounds was checked by TLC on Silica gel 60 F254 plates (Merck) using toluene–ethyl acetate (3:1) as eluent; spots were visualized by treatment with iodine vapor and under UV light (λ 254 nm). The reaction conditions were optimized by HPLC/MS, and the mass spectra (positive electrospray ionization) were recorded with a Waters Acquity UPLC I-Class instrument; Acquity UPLC BEH C18 column (particle size 1.7 μm), eluent acetonitrile–water, flow rate 0.6 mL/min; PDA eλ UV detector and Xevo TQD mass-selective detector. Initial pyrrolediones 1a–1d were synthesized by reaction of the corresponding enamines with oxalyl chloride according to the procedure described in [10].
4-Ethyl 6-methyl 9-amino-2-benzyl-10-cyano-7-methyl-1-oxo-3-phenyl-8-oxa-2-azaspiro[4.5]deca-3,6,9-triene-4,6-dicarboxylate (3a). A solution of 335 mg (1.0 mmol) of pyrroledione 1a, 66 mg (1.0 mmol) of malononitrile, 432 μL (4.0 mmol) of methyl 3-oxobutanoate, and 28 μL (0.2 mmol) of triethylamine in 10 mL of anhydrous acetonitrile was refluxed for 19 h. The mixture was cooled, and the precipitate was filtered off. Yield 338 mg (68%), colorless crystals, mp 206–208°C (from acetone). IR spectrum, ν, cm–1: 3410, 3324, 3217, 3197 (NH2), 2190 (CN), 1733, 1721, 1668, 1626 (C=O). 1H NMR spectrum, δ, ppm: 0.84 t (3H, CH3CH2, J = 7.1 Hz), 2.33 s (3H, Me), 3.52 s (3H, OMe), 3.74–3.86 m (2H, CH3CH2), 4.43 d and 4.48 d (1H each, CH2Ph, J = 15.9 Hz), 6.95–7.03 m (2H, Harom), 7.08–7.13 m (2H, Harom), 7.17 br.s (2H, NH2), 7.18–7.22 m (3H, Harom), 7.35–7.49 m (3H, Harom). 13C NMR spectrum, δC, ppm: 13.4 (CH3CH2), 18.8 (Me), 44.0 (CH2Ph), 49.8 (Cspiro), 51.5 (OMe), 54.5, 58.7 (CH3CH2), 103.5, 112.6, 117.5, 127.1 (3C), 127.9 (2C), 128.0 (2C), 128.4 (2C), 129.4, 129.5, 136.3, 154.7, 159.3, 159.6, 161.3 (COOEt), 165.0 (COOMe), 179.0 (C1=O). Mass spectrum: m/z 521.99 [M + Na]+. Found, %: C 67.63; H 5.18; N 8.39. C28H25N3O6. Calculated, %: C 67.33; H 5.04; N 8.41. M + Na 522.16.
The X-ray diffraction data for compound 3a were obtained with an Xcalibur Ruby single crystal diffractometer with a CCD detector according to standard procedure [Mo Kα radiation, 295(2) K, ω-scanning with a step of 1°]. A correction for absorption was applied empirically using SCALE3 ABSPACK algorithm [11]. Moniclinic crystal system, space group P21/c; C28H25N3O6, M 499.51; unit cell parameters: a = 14.912(3), b = 12.190(2), c = 14.942(3) Å; β = 108.92(2)°; V = 2569.4(10) Å3; Z = 4; dcalc = 1.291 g/cm3; μ = 0.092 mm–1. The structure was solved using SHELXS [12] and was refined against F2 by the full-matrix least-squares method in anisotropic approximation for all non-hydrogen atoms using SHELXL [13] with OLEX2 graphical interface [14]. Hydrogen atoms of the amino group were refined independently in isotropic approximation, and the positions of the other hydrogens were refined according to the riding model. Final divergence factors: R1 = 0.0567 [3899 reflections with I > 2σ(I)], wR2 = 0.1662 (all 6129 independent reflections); goodness of fit S = 1.047. The results were deposited to the Cambridge Crystallographic Data Centre (CCDC entry no. 1981651) and are available at www.ccdc.cam.ac.uk/data_request/cif.
Compounds 3b–3g were synthesized in a similar way.
Ethyl 6-acetyl-9-amino-2-benzyl-10-cyano-7-methyl-1-oxo-3-phenyl-8-oxa-2-azaspiro[4.5]deca-3,6,9-triene-4-carboxylate (3b). Yield 183 mg (38%), colorless crystals, mp 168–169°C (from EtOH). IR spectrum, ν, cm–1: 3390, 3293, 3181 (NH2), 2188 (CN), 1723, 1698, 1682, 1651 (C=O). 1H NMR spectrum, δ, ppm: 0.84 t (3H, CH3CH2, J = 7.1 Hz), 2.34 s (3H, Me), 2.35 s (3H Me), 3.73–3.85 m (2H, CH3CH2), 4.44 s (2H, CH2Ph), 7.05–7.11 m (4H, Harom), 7.12 br.s (2H, NH2), 7.16–7.22 m (3H, Harom), 7.30–7.42 m (3H, Harom). 13C NMR spectrum, δ, ppm: 13.5 (CH3CH2), 19.7 (Me), 31.3 (Me), 44.0 (CH2Ph), 50.3 (Cspiro), 54.9, 58.7 (CH3CH2), 112.1, 114.7, 117.6, 126.6 (2C), 126.9, 127.8 (2C), 128.0 (2C), 128.3 (2C), 129.3, 129.7, 136.6, 154.7, 157.4, 159.9, 161.5 (COOEt), 179.0 (C1=O), 197.1 (COMe). Mass spectrum: m/z 506.05 [M + Na]+. Found, %: C 69.38; H 5.30; N 8.73. C28H25N3O5. Calculated, %: C 69.55; H 5.21; N 8.69. M + Na 506.17.
Diethyl 9-amino-2-benzyl-10-cyano-7-methyl-1-oxo-3-phenyl-8-oxa-2-azaspiro[4.5]deca-3,6,9-triene-4,6-dicarboxylate (3c). Yield 210 mg (41%), colorless crystals, mp 180–182°C (from EtOH). IR spectrum, ν, cm–1: 3454, 3328, 3175 (NH2), 2186 (CN), 1738, 1697, 1667, 1630 (C=O). 1H NMR spectrum, δ, ppm: 0.85 t (3H, CH3CH2, J = 7.1 Hz), 1.11 t (3H, CH3CH2, J = 7.1 Hz), 2.33 s (3H, Me), 3.73– 3.87 m (2H, CH3CH2), 3.97–4.18 m (2H, CH3CH2), 4.34 d and 4.54 d (1H each, CH2Ph, J = 16.0 Hz), 6.99–7.25 m (9H, Harom, NH2), 7.33–7.49 m (3H, Harom). 13C NMR spectrum, δC, ppm: 13.4 (CH3CH2), 13.9 (CH3CH2), 18.9 (Me), 44.2 (CH2Ph), 49.8 (Cspiro), 54.6, 58.7 (CH3CH2), 60.5 (CH3CH2), 103.7, 112.7, 117.6, 126.9 (2C), 127.1, 127.9 (2C), 128.0 (2C), 128.4 (2C), 129.5, 129.5, 136.4, 154.6, 159.1, 159.7, 161.3 and 164.6 (COOEt), 179.0 (C1=O). Mass spectrum: m/z 514.11 [M + H]+. Found, %: C 67.99; H 5.47; N 8.27. C29H27N3O6. Calculated, %: C 67.83; H 5.30; N 8.18. M + H 514.20.
Diethyl 9-amino-10-cyano-7-methyl-2-(4-methylphenyl)-1-oxo-3-phenyl-8-oxa-2-azaspiro[4.5]deca-3,6,9-triene-4,6-dicarboxylate (3d). Yield 272 mg (53%), colorless crystals, mp 181–183°C (from EtOH). IR spectrum, ν, cm–1: 3502, 3406, 3333, 3237, 3208 (NH2), 2190 (CN), 1758, 1694, 1668, 1627 (C=O). 1H NMR spectrum, δ, ppm: 0.90 t (3H, CH3CH2, J = 7.1 Hz), 1.21 t (3H, CH3CH2, J = 7.1 Hz), 2.22 s and 2.36 s (6H, Me), 3.77–3.96 m (2H, CH3CH2), 4.12–4.30 m (2H, CH3CH2), 6.81–6.92 m (2H, Harom), 7.05–7.18 m (4H, Harom), 7.21 br.s (2H, NH2), 7.25–7.35 m (3H, Harom). 13C NMR spectrum, δC, ppm: 13.5 (CH3CH2), 14.1 (CH3CH2), 18.9 (Me), 20.5 (Me), 50.0 (Cspiro), 54.8, 58.9 (CH3CH2), 60.7 (CH3CH2), 103.5, 112.7, 117.5, 127.6 (2C), 127.6 (2C), 129.0 (2C), 129.1, 129.3 (2C), 129.6, 131.5, 137.4, 153.7, 159.5, 159.7, 161.6 and 164.7 (COOEt), 178.2 (C1=O). Mass spectrum: m/z 514.02 [M + H]+. Found, %: C 68.05; H 5.14; N 8.10. C29H27N3O6. Calculated, %: C 67.83; H 5.30; N 8.18. M + H 514.20.
Diethyl 9-amino-10-cyano-7-methyl-1-oxo-2,3-diphenyl-8-oxa-2-azaspiro[4.5]deca-3,6,9-triene-4,6-dicarboxylate (3e). Yield 264 mg (53%), colorless crystals, mp 185–187°C (from EtOH). IR spectrum, ν, cm–1: 3435, 3328, 3265, 3222, 3193 (NH2), 2190 (CN), 1743, 1716, 1673, 1637 (C=O). 1H NMR spectrum, δ, ppm: 0.91 t (3H, CH3CH2, J = 7.1 Hz), 1.22 t (3H, CH3CH2, J = 7.1 Hz), 2.37 s (3H, Me), 3.81–3.94 m (2H, CH3CH2), 4.15–4.28 m (2H, CH3CH2), 6.98– 7.02 m (2H, Harom), 7.13–7.17 m (2H, Harom), 7.20–7.37 m (8H, Harom, NH2). 13C NMR spectrum (DMSO-d6), δC, ppm: 13.5 (CH3CH2), 14.1 (CH3CH2), 19.0 (Me), 50.2 (Cspiro), 54.8, 59.0 (CH3CH2), 60.7 (CH3CH2), 103.5, 112.9, 117.6, 127.6 (2C), 127.8 (2C), 127.9, 128.8 (2C), 129.0 (2C), 129.1, 129.5, 134.2, 153.6, 159.5, 159.8, 161.6 and 164.7 (COOEt), 178.1 (C1=O). Mass spectrum: m/z 500.11 [M + H]+. Found, %: C 67.59; H 5.01; N 8.34. C28H25N3O6. Calculated, %: C 67.33; H 5.04; N 8.41. M + H 500.18
Diethyl 9-amino-10-cyano-2,7-dimethyl-1-oxo-3-phenyl-8-oxa-2-azaspiro[4.5]deca-3,6,9-triene-4,6-dicarboxylate (3f). Yield 223 mg (51%), colorless crystals, mp 218–219°C (from EtOH). IR spectrum, ν, cm–1: 3427, 3285, 3266, 3176 (NH2), 2185 (CN), 1716, 1697, 1678, 1661 (C=O). 1H NMR spectrum, δ, ppm: 0.88 t (3H, CH3CH2, J = 7.1 Hz), 1.14 t (3H, CH3CH2, J = 7.1 Hz), 2.33 s (3H, CH3), 2.74 s (3H, CH3), 3.79–3.85 m (2H, CH3CH2), 4.05–4.13 m (2H, CH3CH2), 7.11 s (2H, NH2), 7.29–7.34 m (2H, Harom), 7.50– 7.55 m (3H, Harom). 13C NMR spectrum, δC, ppm: 13.4 (CH3CH2), 13.8 (CH3CH2), 18.7, 27.5, 49.9 (Cspiro), 54.6, 58.7 (CH3CH2), 60.4 (CH3CH2), 103.4, 112.2, 117.3, 128.2 (2C), 128.4 (2C), 129.6 (2C), 154.6, 159.5, 159.5, 161.4, 164.5, 178.9 (C1=O). Mass spectrum: m/z 437.92 [M + H]+. Found, %: C 63.21; H 5.18; N 9.58. C23H23N3O6. Calculated, %: C 63.15; H 5.30; N 9.61. M + H 438.17.
Diethyl 9-amino-2-benzyl-10-cyano-1-oxo-3,7-diphenyl-8-oxa-2-azaspiro[4.5]deca-3,6,9-triene-4,6-dicarboxylate (3g). Yield 274 mg (48%), colorless crystals, mp 192–193°C (from EtOH). IR spectrum, ν, cm–1: 3406, 3326, 3266, 3256, 3208 (NH2), 2198 (CN), 1735, 1697, 1668, 1627 (C=O). 1H NMR spectrum, δ, ppm: 0.78 t (3H, CH3CH2, J = 7.1 Hz), 0.87 t (3H, CH3CH2, J = 7.1 Hz), 3.80–3.90 m (4H, CH3CH2), 4.41 d and 4.57 d (1H each, PhCH2, J = 16.1 Hz), 7.01–7.14 m (4H, Harom), 7.17–7.24 m (3H, Harom), 7.28 s (2H, NH2), 7.34–7.52 (8H, Harom). 13C NMR spectrum, δC, ppm: 13.1 (CH3CH2), 13.5 (CH3CH2), 44.1 (PhCH2), 50.7 (Cspiro), 54.3, 58.9 (CH3CH2), 60.4 (CH3CH2), 105.3, 112.3, 117.6, 126.7 (2C), 127.0, 127.9 (2C), 128.0 (2C), 128.1 (4C), 128.3 (2C), 129.3, 129.4, 130.0, 133.0, 136.2, 155.1, 156.5, 160.3, 161.3, 164.8, 178.5 (C1=O). Mass spectrum: m/z 576.09 [M + H]+. Found, %: C 71.20; H 5.15; N 7.24. C34H29N3O6. Calculated, %: C 70.94; H 5.08; N 7.30. M + H 576.21.
REFERENCES
Dmitriev, M.V., Silaichev, P.S., Aliev, Z.G., and Maslivets, A.N., Russ. J. Org. Chem., 2011, vol. 47, p. 1165. https://doi.org/10.1134/S1070428011080082
Dmitriev, M.V., Silaichev, P.S., and Maslivets, A.N., Russ. J. Org. Chem., 2015, vol. 51, p. 74. https://doi.org/10.1134/S1070428015010121
Sal’nikova, T.V., Dmitriev, M.V., Bushmeleva, E.V., Silaichev, P.S., and Maslivets, A.N., Russ. J. Org. Chem., 2018, vol. 54, p. 564. https://doi.org/10.1134/S1070428018040073.
Sal’nikova, T.V., Dmitriev, M.V., and Maslivets, A.N., Russ. J. Org. Chem., 2017, vol. 53, p. 128. https://doi.org/10.1134/S1070428017010249
Milovidova, A.G., Belikov, M.Yu., Ievlev, M.Yu., Ershov, O.V., and Nasakin, O.E., Russ. J. Org. Chem., 2018, vol. 54, p. 1790. https://doi.org/10.1134/S1070428018120084
Rahnamay, M., Mahdavi, M., Shekarchi, A.A., Zare, P., and Feizi, M.A.H., Acta Biochim. Pol., 2018, vol. 65, p. 397. https://doi.org/10.18388/abp.2017_1629
Baitha, A., Gopinathan, A., Krishnan, K., and Dabholkar, V.V., J. Heterocycl. Chem., 2018, vol. 55, p. 1189. https://doi.org/10.1002/jhet.3152
Sayed, G.H., Azab, M.E., and Anwer, K.E., J. Heterocycl. Chem., 2019, vol. 56, p. 2121. https://doi.org/10.1002/jhet.3606
Bhat, A.R., Shalla, A.H., and Dongre, R.S., J. Adv. Res., 2015, vol., p. 941. https://doi.org/10.1016/j.jare.2014.10.007
Silaichev, P.S., Dmitriev, M.V., Aliev, Z.G., and Maslivets, A.N., Russ. J. Org. Chem., 2010, vol. 46, p. 1173. https://doi.org/10.1134/S1070428010080105
CrysAlisPro, version 1.171.37.33, Agilent Technologies.
Sheldrick, G.M., Acta Crystallogr., Sect. A, 2008, vol. 64, p. 112. https://doi.org/10.1107/S0108767307043930
Sheldrick, G.M., Acta Crystallogr., Sect. C, 2015, vol. 71, p. 3. https://doi.org/10.1107/S2053229614024218
Dolomanov, O.V., Bourhis, L.J., Gildea, R.J., Howard, J.A.K., and Puschmann, H., J. Appl. Crystallogr., 2009, vol. 42, p. 339. https://doi.org/10.1107/S0021889808042726
Funding
This study was performed under financial support by the Ministry of Science and Higher Education of the Russian Federation (project no. FCHF-2020-0008) and by the Government of Perm Krai.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Sabitov, A.A., Dmitriev, M.V., Belozerova, A.I. et al. Three-Component Reaction of Pyrrolediones, Malononitrile, and Acyclic Enols. Russ J Org Chem 56, 1217–1221 (2020). https://doi.org/10.1134/S1070428020070155
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070428020070155